Form D · Biotechnology
Innara Health, Inc.
Olathe, KS · CIK 0001559922
Offering snapshot reported Aug 10, 2018 · SEC filing
- Reported sold
- $1.49M Offering amount: $1.49M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 26, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 10, 2018 | Initial | $1,493,356 | No comparison | 11 | SEC filing |
| Apr 14, 2016 | Initial | $1,250,000 | No comparison | 1 | SEC filing |
| Oct 11, 2012 | Initial | $2,085,094 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-318987
Source: Form D, filed Aug 10, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dennis E. Beard | Director |
| Maxwell Ellis | Director |
| William H. Lomicka | Director |
| Keith Molzer | Director |
| Michael D. Peck | Director, Executive |
| R. Bruce Richardson | Executive |
| David Stalling | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10900 S. Clay Blair Blvd. Suite 900
Olathe, KS, 66061
Olathe, KS, 66061